FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9727211000001106: Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    31389301000001110 Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    52462401000001113 Amphotericin B (lipid formulation) 50mg powder for solution for infusion vials 10 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Is a Virtual medicinal product pack false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Is pack of Amphotericin (lipid formulation) 50mg powder for solution for injection vials false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Has active ingredient Amphotericin false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Has VMP Amphotericin (lipid formulation) 50mg powder for solution for injection vials false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Has specific active ingredient Amphotericin false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    AmBisome 50mg powder for solution for infusion vials (Gilead Sciences Ltd) 10 vial Is a False Amphotericin (lipid formulation) 50mg powder for solution for injection vials 10 vial Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start